Cristiano Quintini, MD

Appointed
2006

Education & Fellowships

Fellowship - Cleveland Clinic
Multi-Organ Abdominal Surgery
Cleveland, OH USA
2007

Fellowship - Jackson Memorial Hospital
Abdominal Organ Transplant Surgery
Miami, FL USA
2006

Residency - University of Modena (Italy)
General Surgery
Modena, Italy
2005

Medical Education - University of Bologna, School of Medicine
Bologna,
1999

Additional Training

• Advanced Fellowship, Living Donor Liver Transplantation, Cleveland Clinic

Professional Highlights

• Dr. Quintini is an expert in liver surgery. He is involved in the treatment of advanced cancers affecting the liver using innovative approaches such as robotic and minimally invasive surgery. Dr. Quintini is also involved in research on the treatment of ex-vivo tumor resection and perfusion with chemotherapeutic agents for advanced and inoperable liver tumors.

Specialty Interests

Hepatobiliary surgery, Metastatic liver cancers, Neuroendocrine tumors, Hepatocellular carcinoma, Benign liver tumors, Liver cysts, Liver transplantation, Living donor liver surgery, Pediatric liver transplant, Organ recovery and preservation, Portal hypertension

Awards & Honors

• 2011 Cleveland Clinic Innovator Award
• 2013 Cleveland Clinic Innovator Award

Innovations & Patents

• Ex-vivo organ perfusion machine
• Technical innovations in liver transplant surgery and abdominal wall reconstruction

Memberships

• American Society of Transplant Surgeons
• International Liver Transplant Society
• The Transplantation Society
• Cleveland Surgical Society
• American Society of Transplantation

See publications for Cristiano Quintini, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 12/9/2021, Dr. Quintini has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.